National Pharmaceutical Congress II

November 28, 2007

The National Pharmaceutical Congress of 2007 was divided into three rapid-fire sessions entitled The Operating Climate, The Patient/Physician Climate, and The Innovation/Creativity Climate. These sessions provided the opportunity for leaders in the life sciences industry to present reflections, ideas and innovations.


Rapid Fire Session I: The Operating Climate

Welcoming Remarks

Joseph Knott

The Pangaea Group of Companies

Industry Overview

Ronnie Miller

Canada's Research-Based Pharmaceutical Companies (Rx&D)

Greg Glenn

The JBL Group

Graham Jobson

Solvay Pharma Inc.

Andy McClenaghan

P&G Pharmaceuticals Canada

Oxford Debate I

Moderator: Dr. Shafiq Qaadri, MPP,

Parliamentary Assistant to the Minister of Health Promotion

For the affirmative: Dr. David R. Greenberg, D. Dave HealthCare Solutions

For the negative: Marc Lalande,

Council for Continuing Pharmaceutical Education (CCPE)

Resolved: This house believes the role of the professional pharmaceutical representatives is outmoded and recommends an industry-wide reduction of drug reps by 20 percent

Nutritional Break, Networking

Rapid Fire Session II: The Patient/Physician Climate


Bruce Good

IMS Health Canada

Ron Clark

Nycomed Canada

Vince Lamanna

Novo Nordisk Canada Inc.

Michael Luther

Merck Research Laboratories

Ray Chepesiuk

Pharmaceutical Advertising Advisory Board (PAAB)

Audience Q&A

Rapid Fire Session III: The Innovation/Creativity Climate


Mitch Shannon

Chronicle Companies

Mark Beaudet

Paladin Labs Inc.

Patrick Cashman

Lundbeck Canada Inc.

Richard MacKay

Stiefel Canada Inc.

Audience Q&A

Concluding Remarks and Summary

Mitch Shannon

Chronicle Companies

Canadian Healthcare Marketing Hall of Fame Reception

followed by

Canadian Healthcare Marketing Hall of Fame Gala Luncheon


555 Burnhamthorpe Road

Suite 306

Toronto, ON

M9C 2Y3




  • Twitter

© 2021 Chronicle Companies